{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12"}],"title":"CR/CCR"},{"measurements":[{"groupId":"OG000","value":"1"}],"title":"Progressed"},{"measurements":[{"groupId":"OG000","value":"7"}],"title":"Not evaluable (early death)"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Continuous complete remission (for patients in complete remission before treatment) or induced complete remission (for patients not in complete remission before treatment)","groups":[{"description":"Eligible patients are treated with busulfan IV over 2 hours on days -7 to -4, cyclophosphamide IV over 2 hours on days -3 and -2, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1 (BuCyATG) and cord blood is infused on day 0; or are treated with cyclophosphamide IV over 2 hours on days -5 and -4, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1, and undergo TBI twice a day on days -3 to -1 (CyATGTBI) and cord blood is infused on day 0","id":"OG000","title":"Arm 1"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"day +100 after Cord Blood Transplant","title":"Overall Response Rate","type":"PRIMARY","unitOfMeasure":"Participants"}